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Introduction
Postoperative benign biliary stricture usually occurs after surgi-
cal manipulations involving the biliary tree, most notably a
cholecystectomy.1-5 The causes of postoperative biliary strictures may
include direct injury to the bile duct, indirect injury secondary to in-
terruption of vascular supply to a segment of the biliary tree, or fi-
brosis at the site of biliary-enteric anastomosis for various benign and
malignant diseases. Unfortunately, the widespread use of laparoscopic
cholecystectomies in the 1990s resulted in an increased frequency
of bile duct injuries and associated biliary stricture. The estimated
incidence of bile duct injuries, which was 0.2% to 0.3% in a large
series of open cholecystectomies,1,2 has risen to 0.3% to 0.5% for
laparoscopic cholecystectomies.3-5 The reported data have shown that
postoperative benign biliary stricture can occur up to 2.7% after
laparoscopic cholecystectomies.6 On the other hand, House et al.7
demonstrated that 42 of the 1595 patients (2.6%) who underwent
a pancreaticoduodenectomy developed postoperative jaundice secon-
dary to a fibrotic stricture at the bilioenteric anastomosis. Therefore,
postoperative biliary stricture can be a significant disorder that can
occur after various procedures. However, the management of post-
operative biliary stricture remains a difficult challenge because it can
lead to life-threatening complications, such as recurrent cholangitis,
ductal stones, biliary cirrhosis and portal hypertension8-10 even if man-
aged properly. The purpose of this retrospective study was to evalu-
ate the long-term outcome achieved by the percutaneous and surgical
treatment in patients with postoperative benign biliary strictures.
Patients
From March 1991 to December 2007, a total of 19 patients un-
derwent percutaneous and/or surgical management for postopera-
tive benign biliary strictures at this department (Table 1). Any pa-
tients with postoperative biliary stricture due to malignant causes
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The aim of this study was to assess the therapeutic efficacy and long-term outcome of percutaneous and surgical treatment in patients with
postoperative biliary stricture. The subjects consisted of 19 patients with postoperative benign biliary stricture secondary to bile duct injury or
fibrosis at the bilioenterostomy. All of the patients were initially managed by percutaneous transhepatic biliary drainage. Five patients failed to
achieve internalization across the stricture and then underwent a wide hilar hepaticojejunostomy. An additional 4 patients required surgery be-
cause of a complex injury involving the right hepatic artery in one and the occurrence of so-called "blind-loop syndrome" in 3. Hepatobiliary
scintigraphy clearly demonstrated a functional obstacle in the bile flow in these patients. Percutaneous management with an internal/external
catheter placement was accomplished in 10 patients. A successful outcome was achieved in all patients with a mean follow-up 6.7 (range 2-12)
and 5.2 (range 1-12) years for the surgical and percutaneous treatment, respectively. Conclusively, postoperative biliary stricture requires mul-
tidisciplinary management. The surgical repair should therefore be carefully considered for cases with tight stricture, a complex injury, or blind-
loop syndrome. In order to accurately characterize the biliary flow and to select the optimal treatment, hepatobiliary scintigraphy may thus pro-
vide us with helpful information.
ACTA MEDICA NAGASAKIENSIA 53: 23－28, 2008
Keywords: Postoperative biliary stricture; Bile duct injury; Surgical management; Percutaneous management; Hepatobiliary scintigraphy
Yoshitsugu Tajima et al.: Management of Postoperative Biliary Stricture
were excluded. All patients presented with clinical symptoms; recur-
rent cholangitis in 17, obstructive jaundice in 7, or relapsing pneu-
monia due to bronchobiliary fistula in one, and were therefore pre-
pared to undergo treatment. The duration of their symptoms ranged
from 2 months to 21 years. The subjects consisted of 8 men and 11
women with a mean age 57 (range, 37-74) years. In 7 patients, the
original surgery resulting in a bile duct injury or stricture was per-
formed at this hospital. The remaining 12 patients were referred from
outside hospitals after undergoing their original surgery. The stric-
ture of the bile duct secondary to bile duct injury included 9 patients,
in whom the original operations were a laparoscopic cholecystectomy
for cholecystolithiasis in 6, an open cholecystectomy for severe
acute cholecystitis in 2, and a distal gastrectomy for gastric ulcer
in one. The bile duct injuries were identified during the original
surgery in only 3 cases. Although these patients underwent an im-
mediate repair during the same operation by performing a Roux-en
Y hepaticojejunostomy in 2 and a primary suture of the bile duct
in one, they resulted in postoperative biliary strictures. Meanwhile,
the stricture at the site of the biliary-enteric anastomoses per-
formed as an elective operation for various benign and malignant
hepato-biliary pancreatic diseases were recognized in 10 patients,
i.e., the end-to-side hepaticojejunostomy in 9 and the side-to-side
choledochoduodenostomy in one. According to Bismuth's classifi-
cation,11 the level of biliary stricture was classified as type 2 in 5 pa-
tients, type 3 in 4, and type 4 in 10.
Percutaneous transhepatic management
Percutaneous management included the transhepatic direct puncture
of an intrahepatic bile duct, contrast injection, guide wire insertion
across the stricture, stricture dilation, and placement of an internal/
external percutaneous catheter. After an evaluation of the patient's
general condition, as well as the biliary tree with imaging studies, a
percutaneous transhepatic cholangiography and subsequent placement
of a 7-Fr percutaneous transhepatic biliary drainage (PTBD) catheter
(Akita Sumitomo Bakelite, Tokyo, Japan) were performed. The
PTBD was always carried out under the guidance of ultrasonography.
At the initial catheter drainage procedure or during the subsequent
sessions, attempts were made to cross and dilate the stricture. The
stricture was dilated in a stepwise fashion with dilators (Cook,
Bloomington, IN) under the cholangiography, together with or with-
out balloon dilation. An internal/external catheter (Akita Sumitomo
Bakelite, Tokyo, Japan) was then placed across the stricture. The di-
lation procedure was performed during a period of 1-3 weeks with
1-4 sessions for each patient. Biliary stones, if present, were re-
moved by using a basket or were pushed through the bilioenteric
anastomosis. The final internal/external catheter was selected accord-
ing to the grade and condition of the biliary stricture, and then cut at
the skin level, capped on, and left in place for internal biliary drain-
age. Routinely, patients were discharged and returned on an outpa-
tient basis for follow-up cholangiography and biliary catheter ex-
change at 3- to 4-month intervals as indicated. A patient's treatment
was considered to be complete at the time all biliary catheters were
removed. The duration of treatment was defined as the time from
the initial percutaneous procedure until catheter removal.
Surgical management
The surgical management was indicated for the patients whose
percutaneous treatment resulted in failure. The surgical repair con-
sisted of a wide hilar Roux-en Y hepaticojejunostomy in all patients.
After the identification and mobilization of the proximal hepatic
duct, the strictured ductal tissue was resected back to the normal duct
in order to obtain a healthy bile duct (nonscarred, noninflamed,
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Duration Time from
Type of of original surgery to Passage
Case Age Cause of biliary symptoms definitive repair through Follow-up
no. (years) Sex Primary diseases Original surgery biliary stricture stricture Clinical symptoms (months) (months) the stricture Definitive repair * Outcome (months)
1 39 F Cholecystolithiasis Laparoscopic cholecystectomy Bile duct injury IV Cholangitis, jaundice 4 4 No Hepaticojejunostomy successful 21
2 55 M Cholecystolithiasis Open cholecystectomy Bile duct injury III Cholangitis, jaundice 132 156 No Hepaticojejunostomy successful 49
3 47 M Cholecystolithiasis Laparoscopic cholecystectomy Bile duct injury II Cholangitis, jaundice 35 35 No Hepaticojejunostomy successful 66
4 53 F Cholecystolithiasis Laparoscopic cholecystectomy Bile duct injury II Jaundice 3 3 No Hepaticojejunostomy successful 71
5 45 F Cholecystolithiasis Open cholecystectomy Bile duct injury IV Cholangitis, jaundice 3 3 No Hepaticojejunostomy successful 149
6 72 M Cholecystolithiasis Laparoscopic cholecystectomy Bile duct injury IV Cholangitis 30 56 Yes Percutaneous (16F, 30M) successful 30
7 74 F Cholecystolithiasis Laparoscopic cholecystectomy Bile duct injury II Cholangitis 4 12 Yes Percutaneous (16F, 12M) successful 63
8 60 M Gstric ulcer Distal gastrectomy Bile duct injury III Cholangitis, jaundice 4 4 Yes Percutaneous (10F, 8M) successful 57
9 37 M Cholecystolithiasis Laparoscopic cholecystectomy Bile duct injury IV Cholangitis 80 108 Yes Right hepatectomy successful 69
10 51 F CBD Hepaticojejunostomy Stomal fibrosis III Cholangitis 26 26 Yes Hepaticojejunostomy successful 44
11 53 F Hepaticolithiasis Hepaticojejunostomy Stomal fibrosis II Cholangitis 24 276 Yes Hepaticojejunostomy successful 123
12 50 F CBD Hepaticojejunostomy Stomal fibrosis II Cholangitis 58 62 Yes Hepaticojejunostomy successful 125
13 57 M Cholangioma Left hepatectomy Stomal fibrosis IV Cholangitis 2 6 Yes Percutaneous (10F, 8M) successful 12
14 71 F Gallbladder carcinoma Pancreaticoduodenectomy Stomal fibrosis III Jaundice 11 11 Yes Percutaneous (14F, 12M) successful 47
15 61 F Hepaticolithiasis Hepaticojejunostomy Stomal fibrosis IV Cholangitis 93 96 Yes Percutaneous (14F, 14M) successful 52
16 68 F Gallbladder carcinoma Right hepatic trisegmentectomy Stomal fibrosis IV Cholangitis, pneumonia 14 84 Yes Percutaneous (14F, 14M) successful 53
17 60 M IPMN of the pancreas Pancreaticoduodenectomy Stomal fibrosis IV Cholangitis 4 24 Yes Percutaneous (10F, 12M) successful 64
18 56 M Hepaticolithiasis Left hepatectomy Stomal fibrosis IV Cholangitis 189 192 Yes Percutaneous (16F, 8M) successful 92
19 66 F Hepaticolithiasis Choledochoduodenostomy Stomal fibrosis IV Cholangitis 250 252 Yes Percutaneous (16F, 11M) successful 152
Table 1. Clinical features of patients who received percutaneous and/or surgical management for postoperative benign biliary strictures
CBD: Congenital biliary dilatation, IPMN: intraductal papillary mucinous neoplasia
* In parentheses are the size (F: French) and the duration (M: month) of catheter left in place for biliary stricture.
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nonischemic) for a high-quality bilioenteric anastomosis. A Roux-
en Y jejunal limb, approximately 40 cm in length, was prepared in
a retrocolic position for the tension-free anastomosis. The
hepaticojejunostomies were performed routinely at the hepatic hilar
in a wide opening, by using a single layer of interrupted absorbable
4-0 sutures. Individual anastomoses were performed in the cases
involving more than one major duct.
Follow-up study
After definitive treatment, a follow-up was obtained in all patients
as outpatients at this hospital. The patient's status was considered as
successful if there were no symptoms or transitory mild symptoms
related to biliary tract disease, requiring neither invasive radiologic
nor surgical treatment, were present. The patients were considered to
be treatment failures when an invasive radiologic or surgical man-
agement was necessary to treat any ongoing symptoms or stricture
recurrence.
Results
All patients were initially managed with a PTBD and the place-
ment of a transhepatic catheter to control ongoing cholangitis or to
decompress biliary obstruction, or both, and to define the proximal
bile duct anatomy. The PTBD was performed via the left side of
the liver in 8 patients, the right side in 5, and both sides in 6.
At the initial cholangiography or during the subsequent sessions,
the passage of neither a guide wire nor the contrast material through
the stricture to the distal bile duct or the anastomosed intestinal
tract was recognized in 5 patients due to tight strictures (Figure 1).
All of these cases had been referred from outside hospitals after
presenting with biliary strictures secondary to bile duct injuries dur-
ing a laparoscopic cholecystectomy in 3 and an open cholecystectomy
in 2. Subsequently, an endoscopic approach was employed for these
patients, however, these attempts failed. They were therefore prepared
for surgical management by means of a wide hilar hepaticojejunostomy.
The remaining 14 patients underwent a percutaneous dilation of
the strictures with an internal/external biliary drainage catheter. Of
these, 4 patients with a hepaticojejunostomy finally required a sur-
gical repair because of recurrent stricture in one and severe
cholestasis presenting with recurrent cholangitis in 3. In the former,
a hepaticojejunostomy for a bile duct injury during a laparoscopic
cholecystectomy resulted in a recurrent anastomotic stricture despite
repeated percutaneous treatment for 9 years. In this patient, moreo-
ver, injury to the right hepatic artery was discovered 8 years after the
initial operation (Figure 2) and a delayed bile excretion in the right
liver was prominent on the hepatobiliary scintigraphy with Tc-99m
Sn-N-pyridoxyl-5-methyltryptophan (99mTc-PMT) (Figure 3). A
right hepatectomy along with a left sided hepaticojejunostomy was
necessary for this patient, and a histological examination of the
25
Figure 1. A tight anastomotic stricture after a hepaticojejunostomy for an
intraoperative bile duct injury. Cholangiography via the initial percutaneous
transhepatic catheter shows no passage of contrast material through the
stricture. Numerous biliary stones are seen in the intrahepatic bile ducts.
Figure 3. Hepatobiliary scintigraphy with Tc-99m Sn-N-pyridoxyl-5-
methyltryptophan (99mTc-PMT) demonstrates residual activity in the
right hepatic lobe 120 min after the injection of the tracer.
Figure 2. Selective hepatic arteriography demonstrates a right hepatic arterial
obstruction (arrow). The right anterior and posterior hepatic arteries commu-
nicate with the middle hepatic artery through intrahepatic collateral vessels.
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resected liver revealed evidence of periportal and periductal fibrosis.
In the latter, a delayed hepatic clearance and stagnancy of the tracer
in the proximal jejunal loop were demonstrated on the hepatobiliary
scintigraphy even after a completion of percutaneous stricture dila-
tion, thus suggesting a functional disorder of the proximal jejunal
loop for a Roux-en Y hepaticojejunostomy. Following the surgical
removal of the jejunal loop, a wide hilar hepaticojejunostomy with
a newly created Roux-en Y limb was performed in these patients, and
resulted in a normal hepatic clearance and a normal bile transit through
the jejunal loop on the postoperative hepatobiliary scintigraphy (Figure
4). There were no operative deaths and a successful outcome was
achieved in all 9 patients who underwent a definitive surgical re-
pair with a mean postoperative follow-up 6.7 (range 2-12) years.
Percutaneous transhepatic management was accomplished in 10
patients, including a case with a bronchobiliary fistula detected by
hepatobiliary scintigraphy.12 The final internal/external biliary drain-
age catheter ranged 10- to 16-Fr in size. Balloon dilation was simul-
taneously performed in 9 cases. Biliary stones were recognized in 5
patients and they were completely removed using a basket or were
pushed through the bilioenteric anastomosis. The lengths of catheter
placement were 8, 8, 8, 11, 12, 12, 12, 14, 14, and 30 months with
a mean duration of 13.6 months (Figure 5). During the catheter
treatment, a high quality of life was reported in all patients. After the
removal of percutaneous catheters, neither recurrence of the biliary
stricture nor stricture-related clinical symptoms requiring invasive
radiologic or surgical treatment were found with a mean follow-up
of 5.2 (range 1-12) years.
Discussion
Injuries to the bile ducts and subsequent biliary strictures associ-
ated with laparoscopic cholecystectomies are serious and potentially
life-threatening complications and the incidence of bile duct inju-
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Figure 4. A. Hepatobiliary scintigraphy shows
a delayed hepatic clearance and a residual activity
of the tracer in the proximal jejunal loop (100
min after injection of the tracer). B. Hepatobiliary
scintigraphy after a definitive surgery in the
same patient as in Figure 4A demonstrates a
normal hepatic clearance and a normal bile
transit through the newly created jejunal loop
(80 min after injection of the tracer).
Figure 5. A. Bile duct stricture after a primary
suture for a bile duct injury during a laparoscopic
cholecystectomy. The passage of contrast ma-
terial through the stricture was possible. B. A
cholangiogram just before the removal of
percutaneous transhepatic catheter. The stric-
ture is well resolved. In this patient, a 16-Fr
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ries during laparoscopic cholecystectomy remains constant even after
overcoming the "learning curve". In addition, biliary injuries sus-
tained during laparoscopic cholecystectomies tend to be more com-
plex, often involving major vessels, in comparison to the open pro-
cedure.1,13 In the present series of 19 patients with postoperative
biliary strictures, 6 cases were associated with bile duct injuries dur-
ing a laparoscopic cholecystectomy and one of them suffered a con-
comitant right hepatic arterial occlusion. This resulted in a recurrent
stricture at the site of hepaticojejunostomy and then required a right
hepatectomy 9 years after the initial operation to resolve. There are
some reports of such patients with complex injuries during a
laparoscopic cholecystectomy, requiring a hepatectomy14-16 and even
liver transplantation.17,18 Schmidt et al.19 demonstrated that 11 of the
54 patients (20.4%) with bile duct injuries during a laparoscopic
cholecystectomy had a concomitant right hepatic arterial injury and
the outcome of the bile duct reconstruction was worse in these pa-
tients. Bachellier et al.20 also stated that a concomitant hepatic arte-
rial injury is a crucial risk factor for postoperative liver abscess,
stenosis of a hepaticojejunostomy, and stricture in the intrahepatic
biliary tree in the long-term outcome. An assessment for concomi-
tant vascular injuries is therefore essential in managing the patients
with major bile duct injuries. Hepatic arterial revascularization may
therefore be an ideal approach for early recognized injuries.19,20
Fibrotic stricture at the bilioenteric anastomosis is another leading
cause of postoperative biliary strictures.7 In the present study, biliary
stricture at the site of the bilioenteric anastomosis occurred in 10 of
the 19 patients. Following percutaneous management, 3 of these pa-
tients required a surgical repair because of bile stasis secondary to a
functional disorder of the previous jejunal loop. To elucidate the
pathogenesis of recurrent cholangitis in these patients and to select
the optimal treatment strategy, hepatobiliary scintigraphy was useful
since it provided helpful information indicating a so-called "blind-
loop syndrome" i.e., a delayed hepatic clearance and a prominent
stasis of 99mTc in the proximal jejunum loop. In this study, we con-
ducted hepatobiliary scintigraphy on 6 patients who presented with
recurrent cholangitis even after the removal of biliary stricture and
the presence of a unilobar delay of bile excretion in the liver and
a bronchobiliary fistula12 was observed, as well as the presence of
blind-loop syndrome. The efficacy of hepatobiliary scintigraphy in
the assessment of the surgical outcome regarding biliary flow after
bilioenteric anastomosis has been reported,21-23 and the surgical re-
moval of the previous jejunal loop and the creation of a new Roux-
en Y limb for a wide hilar hepaticojejunostomy resulted in a favor-
able outcome. The possibility of a functional obstacle responsible
for recurrent cholangitis24 should therefore be considered when no
mechanical obstructions are observed after percutaneous treatment,
and hepatobiliary scintigraphy is therefore recommended for the as-
sessment of such a disorder because it is noninvasive and can visu-
alize the functional efficacy of bile secretion and excretion after
biliary-enteric anastomosis.
An alternative to surgical management is an interventional approach
including percutaneous and endoscopic techniques. The principal
advantage of interventional treatment is that repetitive stepwise
larger size catheters can achieve an adequate dilation of biliary stric-
ture in individual patients. In the current series, all patients were
initially managed with PTBD and the placement of a transhepatic
catheter, irrespective of the type and the degree of biliary stricture,
because the use of a percutaneous catheter not only allowed us to
effectively control the ongoing cholangitis while also managing
biliary stricture, but it also enabled us to elucidate the anatomy of
the injury. Although 9 patients who had a tight stricture, a complex
injury, or a blind-loop syndrome required surgical repair, the remain-
ing 10 patients were successfully managed using the percutaneous
approach. The outcome of percutaneous management for postopera-
tive biliary strictures tends to vary,25-27 however, the percutaneous ap-
proach should be the first step in management because it is effective
in selected cases and the importance of preoperative delineation of
the biliary anatomy has been clearly demonstated.28 One controversial
aspect about percutaneous treatment is the duration of percutaneous
catheter maintenance necessary to obtain an adequate dilation of
biliary strictures. Kim et al.25 recommended catheter maintenance
of more than 6 months. Kocher et al.26 reported that the mean dura-
tion of percutaneous catheter treatment was 7.5 months with a 3 years
primary clinical success rate of 77%. Based on the present results, it
was thought that the percutaneous catheter should be maintained for
longer than 8 months. Such a long-term percutaneous treatment is
feasible because the majority of patients can be followed up as out-
patients with a good quality of life. Although an endoscopic approach
resulted in treatment failure in our series, the successful endoscopic
treatment of postoperative biliary stricture has been reported in se-
lected patients.29-32
In conclusion, postoperative biliary stricture requires multidisci-
plinary approach for their resolution. A complete workup of the
patient should be done to plan an optimal treatment strategy. The
percutaneous transhepatic approach is the first step in management
to delineate the biliary anatomy and to relieve ongoing cholangitis
and stricture. A surgical repair should be considered for cases with a
tight stricture, a complex injury, or a functional disorder of the previ-
ous jejunal loop for bilioenterostomy. Hepatobiliary scintigraphy may
provide helpful information to determine the precise condition of
biliary flow and thereby take appropriate subsequent measures.
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